Trump's physician says he has taken his first dose of remdesivir, one of the leading experimental coronavirus treatments, and is 'doing very well'

Trump has taken his first dose of remdesivir, an experimental COVID-19 treatment, and is "doing very well," White House physician Sean Conley said in a memo Friday night.
Conley said the president "is not requiring any supplemental oxygen," has completed his first dose of the drug, and is "resting comfortably."
Remdesivir's maker, Gilead Sciences, turned the failed Ebola drug into one of the first effective coronavirus treatments.
Trump has also received Regeneron's experimental antibody drug, according to Conley.
Visit Business Insider's homepage for more stories.

—Kayleigh McEnany (@PressSec) October 3, 2020

—Donald J. Trump (@realDonaldTrump) October 3, 2020

Read the original article on Business Insider

from Business Insider https://ift.tt/3jrDMVf

COVID-19 New Corona